🇺🇸 FDA
Patent

US 8927249

Extended soluble PH20 polypeptides and uses thereof

granted A61KA61K38/00A61K47/60

Quick answer

US patent 8927249 (Extended soluble PH20 polypeptides and uses thereof) held by HALOZYME, INC. expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K38/00, A61K47/60, A61K47/61, A61K47/6435